CEO and Director of Indaptus Therapeutics, Inc. (U.S.: Nasdaq:INDP), Meckler Jeffrey A, buys 11,187 shares worth $65,108

According to Indaptus Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 19 09:16 AM, company CEO and Director, Meckler Jeffrey A disclosed buying 11,187 shares at a cost of $5.82. At the time of this transaction (Nov 18), this trade was worth $65,108 in total. As of Nov 18, Meckler Jeffrey A now owns 25,647 shares in total worth about $143,879.67.

For the last few recent trades made by Indaptus Therapeutics, Inc. (U.S.: Nasdaq:INDP) CEO and Director, Meckler Jeffrey A, we have the following information:

Posted by George Daniels on Friday November 19 2021, 10:35 AM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0